ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
Why it was recalled
New safety information
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Type II2026-09-24
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Type I2026-09-10
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Type II2026-08-31
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.